PO No :PO1259451268-180

Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217181 / 5485915 Sample Receive Date : 26/Aug/2022 10:20AM
Referred By : Dr. Report Status : Final Report
Sample Type : Whole Blood-EDTA Report Date : 26/Aug/2022 01:22PM

HAEMATOLOGY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

Complete Blood Count

Hemoglobin 14.8 g/dL 13.0-17.0 Spectrophotometry
RBC 4.71 10^6/cu.mm 4.5 - 5.5 Impedance
HCT 45.8 % 40 - 50 Calculated
MCV 97.2 fL 83 - 101 RBC pulse measurement
MCH 31.4 pg 27 - 32 Calculated
MCHC 32.3 g/dL 31.5 - 34.5 Calculated
RDW-CV 13.4 % 11.5-14 Calculated
Total Leucocyte Count 7.17 10^3/µL 4 - 10 Impedance
Differential Leucocyte Count
Neutrophils 47.8 % 40-80 Flowcytometery DHHS/
Microscopy
Lymphocytes 43.4 % 20-40 Flowcytometery DHHS/
Microscopy
Monocytes 6.2 % 2-10 Flowcytometery DHHS/
Microscopy
Eosinophils 2.1 % 1-6 Flowcytometery DHHS/
Microscopy
Basophils 0.5 % 0-2 Impedance / Microscopy
Absolute Leucocyte Count
Absolute Neutrophil Count 3.43 10^3/µL 2-7 Calculated
Absolute Lymphocyte Count 3.11 10^3/µL 1-3 Calculated
Absolute Monocyte Count 0.44 10^3/µL 0.2-1 Calculated
Absolute Eosinophil Count 0.15 10^3/µL 0.02-0.5 Calculated
Absolute Basophil Count 0.04 10^3/µL 0.02-0.1 Calculated
Platelet Count 201 10^3/µL 150-410 Impedance /Microscopy
MPV 11.1 fL 6.5 - 12 Calculated
PDW 19 fL 9-17 Calculated

Page 1 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217181 / 5485915 Sample Receive Date : 26/Aug/2022 10:20AM
Referred By : Dr. Report Status : Final Report
Sample Type : Whole Blood-EDTA Report Date : 26/Aug/2022 01:22PM

HAEMATOLOGY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

Comment:

As per the recommendation of International council for Standardization in Hematology, the differential leucocyte counts
are additionally being reported as absolute numbers of each cell in per unit volume of blood.
Test conducted on EDTA whole blood.

Page 2 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217182 / 5485915 Sample Receive Date : 26/Aug/2022 10:41AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 26/Aug/2022 11:38AM

BIOCHEMISTRY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

Creatinine 0.76 mg/dL 0.70-1.30 Alkaline picrate - kinetic

Comment:
Creatinine is a more specific and sensitive indicator of renal disease than Blood Urea Nitrogen.

Uses:

To diagnose renal insufficiency;

Adjusting dosage of renally excreted medications.
Monitoring renal transplant recipients.
Serum creatinine levels are a proxy for reduced skeletal muscle mass.
Serum creatinine measurement is used in estimating the Glomerular Filtration Rate (GFR) for people with Chronic
Kidney disease (CKD) and those with risk factors for CKD (Diabetes Mellitus, hypertension, cardiovascular disease,
and family history of kidney disease).

Increased In: Blockage in the urinary tract, Pre- and postrenal azotemia, Impaired kidney function, Loss of body fluid
(dehydration), Muscle diseases such as gigantism, acromegaly.

Decreased In: Pregnancy, certain drugs (e.g., cimetidine, trimethoprim), Myasthenia Gravis, Muscular dystrophy.

Uric Acid 5.2 mg/dL 3.7-9.2 Uricase/Peroxidase

Comment:
Long-term follow-up of asymptomatic hyperuricemic patients is undertaken because many are at risk for kidney disease that may
develop as a result of hyperuricemia and hyperuricuria; few of these patients ever develop the clinical syndrome of gout.. It is
also used in the diagnosis and monitoring of pregnancy-induced hypertension (pre- eclamptic toxemia). Concentrations in excess
of 6.0 mg/dL at 32 weeks gestation have been noted to be associated with a high perinatal mortality rate.

Blood Urea Nitrogen 11 mg/dL 9.0-23.0 Urease with GLDH

Comment:

Page 3 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217182 / 5485915 Sample Receive Date : 26/Aug/2022 10:41AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 26/Aug/2022 11:38AM

BIOCHEMISTRY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

Elevated Blood Urea Nitrogen can occur with kidney diseases, but it can also happen from a high protein diet, increased
protein breakdown, certain medications, dehydration or burns, GI haemorrhage, cortisol and renal failure. BUN levels often
rise with aging as well.
Abnormally low levels of Blood Urea Nitrogen can be a sign of malnutrition, lack of protein in the diet, and liver disease.

Urea 23.54 mg/dL 19.26-49.22 Calculated

Comment:

Elevated Blood Urea can occur with kidney disease, but it can also happen from high protein diet, increased protein
breakdown, certain medications, dehydration or burns, GI haemorrhage, cortisol and renal failure. Blood urea levels often
rise with aging as well.
Abnormally low levels of Blood Urea can be a sign of malnutrition, lack of protein in the diet, and liver disease.

Note:

Independently, blood urea may not reflect kidney function. For this reason, it is often interpreted in the context of other
measurements, such as creatinine, a breakdown product of the muscle, that is filtered by the kidneys.
In blood, Urea is usually reported as BUN and expressed in mg/dl. BUN mass units can be converted to urea mass units by
multiplying by 2.14.

Page 4 of 14
 PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217180 / 5485915 Sample Receive Date : 26/Aug/2022 10:44AM
Referred By : Dr. Report Status : Final Report
Sample Type : FLUORIDE PLASMA Report Date : 26/Aug/2022 12:14PM

BIOCHEMISTRY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

Glucose - Fasting
Glucose - Fasting 77.00 mg/dL 70 - 99 Hexokinase

Fasting Plasma Glucose 2 hr plasma Glucose Diagnosis

(mg/dL) (mg/dL)
99 or below 139 or below Normal
100 to 125 140 to 199 Pre-Diabetes (IGT)
126 or above 200 or above Diabetes

Reference : American Diabetes Association

Comment:
American Diabetes associations reference range,

Normal <100 mg/dl

Impaired Fasting 100-125 mg/dl
Diabetes >=126 mg/dl

Comment: Random glucose in plasma measures the glucose levels regardless of the last meal intake.

Page 5 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217182 / 5485915 Sample Receive Date : 26/Aug/2022 10:41AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 26/Aug/2022 02:53PM

BIOCHEMISTRY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

Lipid Profile
Cholesterol - Total 135 mg/dL Adults: Enzymatic
Desirable <200,
Borderline High 200-239,
High >=240
Triglycerides 71 mg/dL Normal: <150, GPO
Borderline: 150 - 199,
High:200-499,
Very High>=500
Cholesterol - HDL 43 mg/dL Low(undesirable, high Elimination/catalase
risk):<40
High(desirable, low
risk):>=60
Cholesterol - LDL 77 mg/dL Desirable: <100 Calculated
Above desirable: 100-
129
Borderline high: 130-159
High: 160-189
Very high: >=190
Cholesterol- VLDL 14 mg/dl <30 Calculated
Cholesterol : HDL Cholesterol 3.1 Ratio Desirable : 3.5-4.5 Calculated
High Risk : >5
LDL / HDL Cholesterol Ratio 1.78 Ratio Desirable : 2.5-3.0 Calculated
High risk : >3.5
Non HDL Cholesterol 92 mg/dl Desirable:< 130, Calculated
Above Desirable:130 -
159,
Borderline High:160 -
189,
High:190 - 219,
Very High: >= 220

Page 6 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217182 / 5485915 Sample Receive Date : 26/Aug/2022 10:41AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 26/Aug/2022 02:53PM

BIOCHEMISTRY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

Comment:

Measurements in the same patient can show physiological & analytical variations. Three serial samples 1 week apart
are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for Atherosclerotic
Cardiovascular Disease (ASCVD) risk factors, especially lipid profile. This should be done earlier if there is a family
history of premature heart disease, dyslipidemia, obesity, or other risk factors.
The LAI recommends LDL-C as the primary target and non-HDL-C as a co-primary target, for lipid-lowering therapy.
Non-HDL Cholesterol comprises the cholesterol carried by all atherogenic particles, including LDL, IDL, VLDL & VLDL
remnants, Chylomicron remnants and Lp(a).
Apo B measurement is recommended in high-risk subjects after LDL-C and non-HDL-C goals have been achieved.
Additional testing for Apolipoprotein B, hsCRP, Lp(a ) and LP-PLA2 should be considered among patients with
moderate risk for ASCVD for risk refinement.

Updated 2020 risk stratification approach recommended by the Lipid Association of India

Risk Factors/Markers
Moderate-risk
Major ASCVD Risk Factors Other High risk features nonconventional risk
factors
1. Age ≥45 years in males and 1. Diabetes with 0-1 other major ASCVD Risk factors and no 1. Coronary calcium score
≥55 years in females evidence of target organ damage 100-299
2. Family history of premature
2. CKD Stage 3B or 4 2. Increased carotid IMT
ASCVD
3. Current cigarette smoking and 3. Familial hypercholesterolemia (other than familial 3. Lipoprotein (a) 20-49
tobacco use homozygous hypercholesterolemia mg/dL
4. High blood pressure 4. Extreme of a single risk factor 4. Impaired Fasting Glucose*
5. Increased waist
5. Low HDL-C 5. Coronary calcium score ≥300
circumference**
6. Apolipoprotein B ≥110
6. Non-stenotic carotid plaque
mg/dL
7. Lipoprotein (a) ≥50 mg/dL 7. hsCRP ≥2 mg/L***

Risk groups
Low risk Moderate risk High risk Very High risk Extremely High risk

Page 7 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217182 / 5485915 Sample Receive Date : 26/Aug/2022 10:41AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 26/Aug/2022 02:53PM

BIOCHEMISTRY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

2 Major
≥3 major ASCVD
ASCVD risk Pre-existing ASCVD Category A Category B
risk factor
factors
0-1 major
Low risk group 2 major ASCVD risk
ASCVD risk Diabetes ≥2 other CAD ≥1 feature of very high risk
≥1 moderate- factor with ≥1
factor and major risk factors or group or recurrent ACS (within
risk moderate-risk
Lifetime CVD evidence of target one year) despite LDL-C ≤50
nonconventional nonconventional risk
risk <30% organ damage mg/dL or polyvascular disease
risk factors factors
Lifetime CVD ≥1 other high risk Familial homozygous
risk ≥30% features Hypercholesterolemia

* A fasting blood sugar level from 100 to 125 mg/dl. It should be confirmed by repeat testing; **Waist circumference is to be
measured at the superior border of the iliac crest just after expiration. Increased waist circumference is defined as >90 cm
in men and >80 cm in women. If increased waist circumference is the only risk factor, it should again be measured after 6
months after initiating heart-healthy lifestyle measures; ***On two occasions at least 2 weeks apart. For reclassifying moderate
risk group only.
Newer treatment goals and statin initiation thresholds based on the risk categories proposed by LAI in 2020
Risk groups Treatment Goals Consider Drug Therapy
LDL-C (mg/dL) Non-HDL (mg/dL) LDL-C (mg/dL) Non-HDL (mg/dL)
Extreme Risk Group Category A <50 (Optional goal ≤30) <80 (Optional goal ≤60) ≥50 ≥80
Extreme Risk Group Category B ≤30 ≤60 >30 >60
Very High Risk <50 <80 ≥50 ≥80
High Risk <70 <100 ≥70 ≥100
Moderate Risk <100 ≥100 ≥130
Low risk <100 ≥130* ≥160*
*After an adequate non-pharmacological intervention for at least 3 months

Page 8 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217182 / 5485915 Sample Receive Date : 26/Aug/2022 10:41AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 26/Aug/2022 03:11PM

BIOCHEMISTRY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

Liver Function Test

Bilirubin-Total 0.74 mg/dl 0.3-1.2 Vanadate oxidation
Bilirubin-Direct 0.33 mg/dl 0 - 0.3 Vanadate oxidation
Bilirubin-Indirect 0.41 mg/dL 0.1 - 1.0 Calculated
Protein, Total 7.30 g/dL 5.7-8.2 Biuret
Albumin 4.60 g/dL 3.2-4.8 BCG Dye Binding
Globulin 2.7 g/dl 1.8 - 3.6 Calculated
A/G Ratio 1.7 Ratio 0.8 - 2.1 Calculated
Aspartate Transaminase (SGOT) 22 U/L <34 Modified IFCC
Alanine Transaminase (SGPT) 15 U/L 10-49 Modified IFCC
SGOT/SGPT 1.47 Ratio <1 Calculated
Alkaline Phosphatase 53 U/L 45-129 IFCC Standardization
Gamma Glutamyltransferase (GGT) 13 U/L <73 Modified IFCC

Comment:

LFTS are based upon measurements of substances released from damaged hepatic cells into the blood that gives idea of
the Existence, Extent and Type of Liver damage.
Acute Hepatocellular damage: ALT & AST levels are sensitive index of hepatocellular damage
Obstruction to the biliary tract,Cholestasis and blockage of bile flow:
Serum Total Bilirubin concentration 2) Serum Alkaline Phosphatase (ALP) activity 3) Gamma Glutamyl Transpeptidase
(GGTP) 4) 5`-Nucleotidase
Chronic liver disease: Serum Albumin concentration
Bilirubin results from the enzymatic breakdown of heme. Jaundice is a yellowish discoloration of the skin and mucous
membranes caused by hyperbilirubinemia.
Pre-hepatic or hemolytic jaundice - Abnormal red cells, antibodies,drugs and toxins,Hemoglobinopathies, Gilbert’s
syndrome, Crigler-Najjar syndrome
Hepatic or Hepatocellular jaundice-Viral hepatitis,toxic hepatitis, intrahepatic cholestasis
Post-hepatic jaundice -Extrahepatic cholestasis, gallstones, tumors of the bile duct, carcinoma of pancreas
In viral hepatitis and other forms of liver disease associated with acute hepatic necrosis, serum AST and ALT
concentrations are elevated even before the clinical signs and symptoms of disease appear. ALT is the more liver-specific
enzyme and elevations of ALT activity persist longer than AST activity. Peak values of aminotransferase activity occur

Page 9 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217182 / 5485915 Sample Receive Date : 26/Aug/2022 10:41AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 26/Aug/2022 03:11PM

BIOCHEMISTRY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

between the seventh and twelfth days. Activities then gradually decrease, reaching normal activities by the third to fifth
week. Peak activities bear no relationship to prognosis and may fall with worsening of the patient's condition.
Aminotransferase activities observed in cirrhosis vary with the status of the cirrhotic process and range from the upper
reference limit to four to five times higher, with an AST/ALT ratio greater than 1. The ratio's elevation can reflect the grade
of fibrosis in these patients. Slight or moderate elevations of both AST and ALT activities have been observed after
administration of various medications and chronic hepatic injury such as (1) hemochromatosis, (2) Wilson disease, (3)
autoimmune hepatitis, (4) primary biliary cirrhosis, (5) sclerosing cholangitis, and (6) a1-antitrypsin deficiency. AST activity
also is increased in acute myocardial infarction, progressive muscular dystrophy and dermatomyositis, reaching
concentrations up to eight times the upper reference limit.Slight to moderate AST elevations are noted in hemolytic
disease.
GGT is a sensitive indicator of the presence of hepatobiliary disease, being elevated in most subjects with liver disease
regardless of cause. Increased concentrations of the enzyme are also found in serum of subjects receiving anticonvulsant
drugs, such as phenytoin and phenobarbital.

Page 10 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217182 / 5485915 Sample Receive Date : 26/Aug/2022 10:41AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 26/Aug/2022 03:55PM

Immunology
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

Thyroid Stimulating Hormone - Ultra 2.354 uIU/ml 0.55-4.78 CLIA

Sensitive

Comment:

Reference ranges for TSH (μIU/ml) [As per American thyroid

Pregnancy
Association]
1st
0.1-2.5
trimester
2nd
0.2-3.0
trimester
3rd
0.3-3.0
trimester

TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm
.
The variation is of the order of 50%, hence time of the day has influence on the measured serum TSH concentrations.
TSH is secreted in a dual fashion: Intermittent pulses constitute 60-70% of total amount, background continuous secretion
is 30-40%.These pulses occur regularly every 1-3 hrs.
TSH is a very sensitive and specific parameter for assessing thyroid function and is particularly suitable for early detection
or exclusion of disorders in the central regulating circuit between the hypothalamus, pituitary and thyroid.
Changes in thyroid status are typically associated with concordant changes in T3, T4 and TSH levels.
For the diagnosis of hypothyroidism and hyperthyroidism, sole dependence on TSH should not be done and assay needs
to be interpreted with the clinical condition & other investigations.
Serum TSH level changes significantly in response to even minor changes in thyroid hormones.
Transient increase in TSH level or an abnormal TSH levels can be seen in various nonthyroidal diseases.
Unexpectedly abnormal or discordant thyroid test values may be seen with some rare, but clinically significant conditions
such as central hypothyroidism, TSH-secreting pituitary tumors, thyroid hormone resistance, or the presence of
heterophilic antibodies (HAMA) or thyroid hormone autoantibodies.

Page 11 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217182 / 5485915 Sample Receive Date : 26/Aug/2022 10:41AM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum Report Date : 26/Aug/2022 03:55PM

Immunology
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

TSH T3 T4 Interpretation
High Normal Normal Subclinical Hypothyroidism
Low Normal Normal Subclinical Hyperthyroidism
High High High Secondary Hyperthyroidism
Low High/Normal High/Normal Hyperthyroidism
Non thyroidal illness / Secondary
Low Low Low Hypothyroidism

Page 12 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217183 / 5485915 Sample Receive Date : 26/Aug/2022 10:27AM
Referred By : Dr. Report Status : Final Report
Sample Type : Urine Report Date : 26/Aug/2022 02:10PM

CLINICAL PATHOLOGY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

Urine Routine & Microscopy

Colour PALE YELLOW Pale Yellow
Appearance CLEAR Clear
Specific gravity 1.005 1.003 - 1.035 pKa change
Ph 6.0 4.6 - 8.0 Double Indicator
Glucose NEGATIVE Negative GOD-POD
Protein NEGATIVE Negative Protein Error Principle
Ketones NEGATIVE Negative Nitroprusside
Blood NEGATIVE Negative Peroxidase
Bilirubin NEGATIVE Negative Diazonium
Urobilinogen NORMAL Normal Ehrlich
Leucocyte Esterase NEGATIVE Negative Pyrrole
Nitrite NEGATIVE Negative P-arsanilic acid
Pus cells 1-2 /hpf 0-5 Microscopy
Red Blood Cells NIL /hpf 0-2 Microscopy
Epithelial cells 1-2 /hpf Few Microscopy
Casts NIL /lpf Nil Microscopy
Crystals NIL Nil Microscopy
Yeast NIL Nil Microscopy
Bacteria NIL Nil Microscopy

Comment:

Pre-test condition to be observed while submitting the sample-first void, mid stream urine, collected in a clean, dry, sterile
container is recommended for routine urine analysis, avoid contamination with any discharge from vaginal, urethra,
perineum, as applicable, avoid prolonged transit time & undue exposure to sunlight.
During interpretation, points to be considered are Negative nitrite test does not exclude the urinary tract infections. Trace
proteinuria can be seen with many physiological conditions like prolonged recumbency, exercise, high protein diet. False
positive reactions for bile pigments, proteins, glucose and nitrites can be caused by peroxidase like activity by
disinfectants, therapeutic dyes, ascorbic acid and certain drugs.

Page 13 of 14
PO No :PO1259451268-180
Name : Mr.SHUBHAM :
Age/Gender : 26/Male Registration Date : 25-Aug-22 02:18 PM
Patient ID : OKH241377 Collection Date : 25/Aug/2022 10:23AM
Barcode ID / Order ID : A9217183 / 5485915 Sample Receive Date : 26/Aug/2022 10:27AM
Referred By : Dr. Report Status : Final Report
Sample Type : Urine Report Date : 26/Aug/2022 02:10PM

CLINICAL PATHOLOGY
GOOD HEALTH SILVER PACKAGE
Test Name Result Unit Bio. Ref. Range Method

*** End Of Report ***

Page 14 of 14
Thank you for choosing us as your healthcare partner
Tata 1mg Labs, India’s trusted diagnostics lab chain, has a nationwide network of 9
diagnostics labs, serving over a million customers each year across 35 cities. Equipped
with the latest technologies, our diagnostics chain brings home to you an extensive
catalog of tests.

20 Lakh+ Detailed Accurate & Sample collection by

satisfied customers information of timely reports vaccinated & certified
each test professionals

What makes us India’s trusted diagnostic services?

1. All samples are processed under the

supervision of highly qualified Pathologists,
Microbiologists, Biochemists and Molecular
Scientists. Our labs are operated by a team
of expert medical professionals with a
collective experience of 200+ years.

2. We ensure that all tests are carried out with

utmost care, in accordance with the
accepted national and international norms
and clinical safety standards such as good
laboratory practices by WHO and ICMR.

3.
“
Our lab test reports undergo multiple levels
of meticulous processing and detailed
verification. Every single report goes
“
through a 3-step review process and is
verified by a doctor holding a postgraduate
degree in Pathology or Microbiology.

CONFUSED ABOUT YOUR REPORTS?

Now, consult India’s top doctors from the
comfort of your home.

CLAIM YOUR FREE CONSULTATION

Why are regular health checkups important?
Help in early detection of diseases Help cut down any future
& prevent severe complications healthcare cost

Identify underlying stress-related Help monitor overall health of

disease/condition you & your family

Our most booked

preventive health checkups:

Comprehensive Full Body Good Health Silver

Checkup Gold (70+ Tests) Package (50+ Tests)

*Prices are subject to change as per location

CBC, Thyroid Profile, Lipid Profile, CBC, Diabetes Screening, Lipid Profile,
Iron Profile, Vitamin Profile, CRP, Thyroid Profile, Kidney Panel,
Urine Routine Liver Panel

A full body check up that screens you Helps you make better & healthier
for common health conditions related lifestyle choices by giving you an
to thyroid, heart, liver, kidney, bones overview of your health status
and blood

Book now starting at ₹1999* Book now starting at ₹599*

Check out and compare our most

COMPARE HERE
popular packages here
Common symptoms may indicate underlying
health conditions!

What's causing your fever?

Get timely diagnosis with

BOOK NOW
Fever Package Extensive
Tests for Dengue, Malaria, Typhoid & Chikungunya

Feeling tired and fatigued often?

Check your Vitamin D,

BOOK NOW
B12 & B9 levels with
Vitamin Profile

For booking assistance, contact us on

Call: 1800-212-2323 WhatsApp: 9717-719-814

Book your test on 1mg.com/labs

Home sample Free doctor 100% vaccinated Trusted &

collection consultation phlebotomists certified labs

Conditions of Laboratory Testing & Reporting:

*Test results released pertain to the sample,as received *Laboratory investigations are only a tool to facilitate in arriving at
a diagnosis and should be clinically correlated by the interpreting clinician.*Result delays may happen because of
unforeseen or uncontrollable circumstances.*Test report may vary depending on the assay method used *Test results may
show inter-laboratory variations *Test results are not valid for medico-legal purposes *Please mail your queries related to
test results to Customer Care mail ID [email protected]

Disclaimer: Results relate only to the sample received. Test results marked “BOLD” indicate abnormal results i.e., higher or
lower than normal. All lab test results are subject to clinical interpretation by a qualified medical professional. This report
cannot be used for any medico-legal purposes. Partial reproduction of the test results is not permitted. Also, TATA 1mg
Labs is not responsible for any misinterpretation or misuse of the information. The test reports alone may not be conclusive
of the disease/condition, hence clinical correlation is necessary. Reports should be vetted by a qualified doctor only.